Počet záznamov: 1
parasympatomimetiká
SYS d010277 LBL 00000cz--a2200000n--4500 005 20250606214531.2 008 990101|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a D27.505.696.663.050.675 066 $a 01 $c 03 150 $a parasympatomimetiká $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a parasympatikomimetiká $2 slo 550 $7 sllk_us_auth*d008916 $Y Miotics $w b $a miotiká 550 $7 sllk_us_auth*d010275 $Y Parasympathetic Nervous System $w b $a systém nervový parasympatikový 550 $7 sllk_us_auth*d002800 $Y Cholinesterase Inhibitors $w p $a inhibítory cholínesteráz 550 $7 sllk_us_auth*d018721 $Y Muscarinic Agonists $w p $a agonisty muskarínové 680 9-
$i Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here. $2 eng 680 $a note entry term PARASYMPATHOMIMETIC EFFECT: use only for the parasympathomimetic effect of a chemical substance $2 eng 750 -2
$a Parasympathomimetics $2 eng 980 $x M
Počet záznamov: 1